US filing analysis · 10-Q
Sorted by SEC acceptance time (filing date when unavailable). Page 27 · 30 shown · up to 30 per page
TEL
TE Connectivity said net sales for Q3 of fiscal 2025 increased 13.9%, with organic net sales growth of 9.1%. Net sales for the 9 months increased 6.2%, with organic net sales growth of 4.8%, and Richards Manufacturing contributed net sales of $73 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 25, 2025
TE ConnectivityTEL$199.97-5.32%
NDAQ
Nasdaq said it welcomed 38 U.S. operating company IPOs that raised more than $3.5 billion in proceeds in Q2 and extended its listing leadership to 46 consecutive quarters. The company said market value brought in from exchange switches to Nasdaq in Q2 was nearly $50 billion.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 25, 2025
NasdaqNDAQ$103.01-0.90%
HAL
Halliburton said total company revenue for Q2 2025 was $5.5 billion, a 6% decrease compared with Q2 2024, and operating income was $727 million, down from $1.0 billion in Q2 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 25, 2025
HalliburtonHAL$30.53-3.78%
DOW
Dow said net sales for Q2 2025 were $10.1 billion, down 7% from $10.9 billion in Q2 2024. Local price declined 7%, volume decreased 1%, and currency had a favorable impact of 1%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 25, 2025
DowDOW$29.22-3.40%
DOC
Healthpeak Properties cited a decrease in gains on sales of real estate, a decrease in Adjusted NOI from its outpatient medical and lab segments, an increase in loan loss reserves, and an increase in transaction costs as factors for the decrease in net income applicable to common shares for the 3 months ended June 30, 2025.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 25, 2025
Healthpeak PropertiesDOC$19.24+0.26%
CNC
Centene said the HBR for Q2 2025 was 93.0%, compared to 87.6% in the year-ago quarter. GAAP diluted loss per share was $(0.51) and adjusted diluted loss per share was $(0.16). The company cited a reduction in its net 2025 Marketplace risk adjustment revenue transfer estimate as the primary driver of both per-share losses.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 25, 2025
CenteneCNC$63.78-2.74%
CME
CME Group said total contract volume in Q2 2025 and the first six months increased compared with the same periods in 2024. The company cited uncertainty surrounding tariffs and Federal Reserve interest rate policy as factors that contributed to the increase in volume.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 25, 2025
CME GroupCME$307.7+0.45%
WST
West Pharmaceutical Services said consolidated net sales for the quarter ended June 30, 2025 increased $64.4 million (9.2%) from the same period in the prior year, including a favorable foreign currency translation impact of $16.5 million. Excluding foreign currency translation effects, consolidated net sales increased $47.9 million (6.8%).
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
West Pharmaceutical ServicesWST$390.3-1.61%
WAB
Wabtec said net sales for the 3 months ended June 30, 2025 were $2.71 billion, an increase of $62 million, or 2.3%, compared to the same period in the prior year. The company cited $27 million from acquisitions and $11 million from favorable changes in foreign exchange.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 24, 2025
WabtecWAB$269.31-4.07%
VRSN
Verisign said revenues for the 3 and 6 months ended June 30, 2025 were $409.9 million and $812.2 million, respectively, representing increases of 6% and 5% compared to the same periods in the prior year. Operating income was $280.7 million and $551.9 million, respectively, representing an increase of 5% compared to the same periods in the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 24, 2025
VerisignVRSN$306.97+0.17%
VLO
Valero Energy said revenues for Q2 2025 decreased $4.6 billion compared to Q2 2024, and adjusted operating income decreased to $1.0 billion from $223 million. The company cited a decline in prices for products sold by its Refining segment as the reason for the revenue decrease.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
Valero EnergyVLO$334.18-1.26%
TXT
Textron said revenues for Q2 2025 increased $189 million, or 5%, compared with Q2 2024. The company cited higher Bell revenues of $222 million and higher Textron Aviation revenues of $42 million as factors, while Industrial revenues decreased $75 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 24, 2025
TextronTXT$79.62-1.85%
SHW
Sherwin-Williams said consolidated net sales for Q2 2025 increased 0.7% to $6.315 billion, and diluted net income per share decreased 14.3% to $3.00 from $3.50.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 24, 2025
Sherwin-WilliamsSHW$339.74-0.03%
ROL
Rollins said revenues for the quarter ended June 30, 2025 were $999.5 million, an increase of 12.1% from Q2 2024, with organic revenue growth of 7.3% and acquisitions contributing 4.8%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
RollinsROL$37.82-0.40%
MCO
Moody's said MA revenue grew 11% in Q2 2025 and MIS revenue was in line with the prior year. The company said the decline in bank loan issuance in MIS was offset by higher investment-grade issuance and monitoring fees.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
Moody'sMCO$466.83-1.06%
KO
The Coca-Cola Company said net cash used in operating activities during the 6 months ended June 27, 2025 was $1,391 million, compared to net cash provided by operating activities of $4,113 million in the prior-year period, and cited the $6,069 million portion of the $6,173 million final milestone payment for fairlife as a factor in the decrease.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
The Coca-Cola CompanyKO$96.8+0.74%
JNJ
Johnson & Johnson said worldwide sales for Q2 of fiscal 2025 were $23.7 billion, an increase of 5.8%, and sales for the 6 months were $45.6 billion, an increase of 4.1%. The company said the negative impact of the Stelara sales decline on operational sales for the 6 months was approximately 5.9%.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
Johnson & JohnsonJNJ$270.47+1.25%
JBHT
J.B. Hunt said consolidated operating revenues for Q2 2025 were $2.93 billion, flat with Q2 2024, and operating income decreased from $205.7 million in 2024 to $197.3 million.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
J.B. HuntJBHT$218.54-3.03%
INTC
Intel announced and initiated its 2025 Restructuring Plan in Q2 2025 and said it expects to recognize total charges of approximately $1.9 billion, with cumulative charges as of June 28, 2025 of $1.8 billion.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
IntelINTC$51.38-7.79%
HON
Honeywell said its backlog as of June 30, 2025 increased 14% compared with June 30, 2024 to $36.6 billion. The company described backlog as the estimated remaining value of work to be performed or products to be shipped under firm contracts.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
HoneywellHON$212.94-2.25%
FISV
Fiserv said total revenue in Q2 2025 increased $409 million, or 8%, compared with the year-earlier period, and increased $656 million, or 7%, in the first six months. The company cited higher processing revenue across its businesses and increased data and analytics sales in both periods as factors for the growth.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
FiservFISV$55.93-1.22%
CMG
Chipotle Mexican Grill said comparable restaurant sales decreased 4.0% for the 3 months ended June 30, 2025. The company attributed the decrease to lower transactions of 4.9%, offset by a 0.9% increase in average check. For 2025, management is anticipating about flat comparable restaurant sales.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
Chipotle Mexican GrillCMG$35.55-2.07%
AOS
The company said sales for Q2 2025 were $1,011.3 million, lower than Q2 2024 of $1,024.3 million, and gross profit margin was 39.3%, up from 38.7% in Q2 2024.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
A. O. SmithAOS$63.24-0.74%
ALLE
Allegion said net revenues for the 3 months ended June 30, 2025 increased 5.8%, or $56.4 million, compared with the same period in the prior year. Operating income increased $10.7 million, but operating margin declined to 21.5% from 21.6% in the same period of the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 24, 2025
AllegionALLE$183.61-1.27%
TMUS
T-Mobile said total revenues for the 3 months ended June 30, 2025 increased $1.4 billion (7%), postpaid revenues increased $1.2 billion (9%), and wholesale and other service revenues decreased $221 million (24%).
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 23, 2025
T-Mobile USTMUS$165.6+1.89%
LII
Lennox International said net sales for Q2 2025 were $1,501 million, up 3% from the same period in the prior year, and operating income increased $34 million to $354 million. Diluted earnings per share were $7.82, compared to $6.87 in the same period in the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 23, 2025
Lennox InternationalLII$334.49-2.37%
ISRG
Intuitive Surgical said total revenue for the 3 months ended June 30, 2025 increased 21% to $2.44 billion from $2.01 billion in the prior-year period. The company cited increases of 18% in instruments and accessories, 28% in systems, and 23% in service.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 23, 2025
Intuitive SurgicalISRG$399.62-1.87%
EQT
EQT said net income attributable to EQT Corporation for the 3 months ended June 30, 2025 was $784.1 million, or $1.30 per diluted share, compared to $9.5 million, or $0.02 per share, for the same period in the prior year. Net income for the 6 months was $1,026.3 million, or $1.70 per share, compared to $113.0 million, or $0.25 per share, for the same period in the prior year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 23, 2025
EQTEQT$48.89-0.83%
DHI
D.R. Horton said net income attributable to the company decreased 24% to $1.0 billion for the quarter ended June 30, 2025, compared to $1.4 billion in the prior year period, and diluted net income per common share decreased 18% to $3.36 compared to $4.10.
US filing analysisUS10-Q · Quarterly reportPublished Oct 10, 2026 (UTC)SEC filing date Jul 23, 2025
D.R. HortonDHI$145.44+1.96%
CSX
CSX said operating income for Q2 2025 was $1.3 billion, down $165 million or 11% year over year, and operating margin was 35.9%, down 320 basis points. Earnings per diluted share were $0.44, down $0.05 or 10% year over year.
US filing analysisUS10-Q · Quarterly reportPublished Oct 11, 2026 (UTC)SEC filing date Jul 23, 2025
CSXCSX$49.1-1.76%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.